Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.
Gabizon A, Chisin R, Amselem S, Druckmann S, Cohen R, Goren D, Fromer I, Peretz T, Sulkes A, Barenholz Y.
Gabizon A, et al.
Br J Cancer. 1991 Dec;64(6):1125-32. doi: 10.1038/bjc.1991.476.
Br J Cancer. 1991.
PMID: 1764376
Free PMC article.
Clinical Trial.
Pharmacokinetic and imaging studies in 19 patients receiving liposome-entrapped adriamycin (L-ADM) were carried out within the framework of a Phase I clinical trial (Gabizon et al., 1989a). The formulation of L-ADM tested consisted of 0.2 microM-extruded multilamell …
Pharmacokinetic and imaging studies in 19 patients receiving liposome-entrapped adriamycin (L-ADM) were carried out within the framework of …